AMIR H. NASHAT, SC.D.
Profile
First Name
: AMIR
Middle Name
: H.
Last Name
: NASHAT, SC.D.
Related Companies
Titles
Company Name
Related People
DIRECTOR
SRINI AKKARAJU, JAMES C. BLAIR, JOHN T. BLAKE, FREDERIC CHEREAU, JOHN K. CLARKE, TIMOTHY P. COUGHLIN, KATHRYN FALBERG, MARK GOLDBERG, JEFFREY S. HATFIELD, NANCY D. KRUEGER, JOHN D. MENDLEIN, AMIR NASHAT, ED PENHOET, SANUJ K. RAVINDRAN, PAUL SCHIMMEL, SANJAY S. SHUKLA, AKKARAJU SRINIVAS, DAVID WEINER
DIRECTOR
SRINIVAS AKKARAJU, M.D., SRINIVAS AKKARAJU, M.D., PH.D., REGINA BARZILAY, PH.D., BRUCE BEUTEL, OLIVER BRANDICOURT, M.D., OLIVIER BRANDICOURT, M.D., GUISEPPE A. CIARAMELLA, PH,D., GIUSEEPPE CIARAMELLA, PH.D., GIUSEPPE CIARAMELLA, PH.D., GIUSEPPE A. CIARAMELLA, PH.D., JUERGEN ECKHARDT, M.D., JURGEN ECKHARDT, M.D., LORI ESCOBEDO, ANTHONY A. HYMAN, PH.D., ISAAC A. KLEIN, M.D., PH.D., ELISABETH LEIDERMAN, MARK MURCKO, PH.D., AMIR H. NASHAT, AMIR H. NASHAT, PH.D., AMEET NATHWANI, M.D., STEVEN NEIER, PH.D., FABIO PUCCI, PH.D., JOEL D. SENDEK, RICHARD A YOUNG, PH.D., RICHARD A. YOUNG, PH.D.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2017-08-31
